Thursday

23rd Sep 2021

Commission plans strategy to 'maximise' vaccine access

  • Health commissioner Stella Kyriakides said she is in talks with a 'a large number of companies working with the vaccines' (Photo: European Commission)

The EU Commission plans to come forward with a strategy in mid-June to "maximise access to the vaccine" against coronavirus.

"We are in conversation with a large number of companies working with the vaccines," EU health commissioner Stella Kyriakides told a group of journalists on Thursday (4 June).

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

"We need to be sure that we have as much as possible a coordinated approach. I am working with member states and industry on this, in order to define the needs and maximise access to the vaccine when it becomes available," the Cypriot commissioner said.

"The vaccine cannot be a luxury for a selected few. It has to be accessible to all citizens everywhere," she added.

The EU commission, in the meantime, is seeking a mandate from member states to negotiate with pharmaceutical companies on funding and procuring possible vaccines and to secure doses for all citizens.

The issue was discussed on Wednesday among EU diplomats, with few reactions to the commission's proposal, and no decision made, one official said.

Details of the plan will be on the agenda when EU health ministers meet next Friday (12 June).

Ministers will also discuss how a separate track of vaccine-funding by an alliance of member states - the Netherlands, France, Germany and Italy - and the commission's ambitions would complement each other.

The four member states are seeking to start talks with drug makers and jointly explore various promising vaccine initiatives.

Once those initiatives are identified, the countries will look into funding or joint procurement.

The aim of the so-called "Inclusive Vaccine Alliance" is to secure enough vaccines for Europe and is open for any EU countries to join.

The "alliance" argues that while the commission's mandate takes time, member states are ready to start negotiating immediately, and speed is a key question in the search for vaccine.

The countries look at it as kickstarting the process, which is open to other EU countries and commission expertise.

Kyriakides said she thinks that everybody needs to be onboard and working effectively together in order to reach the vaccine.

"We are in close contact and it is understandable that member states want to move forward in that direction because they have concerns in terms of finding a vaccine as quickly as possible," she said - emphasising that the alliance is open to other member states.

EU countries are eager to ensure access to any vaccine, over fears that China or the United States may want to control purchases of such vaccines.

Kyriakides argued for a global approach.

"I don't see the issue to do with finding a vaccine to be a fight or a competition, because when you deal with a pandemic as a global public health issue as we all have, we know we are all in this together, she said.

"We need to understand this. We can only move forward if we are all in this together," the commissioner said.

The commission also plans to unleash €2bn from the Emergency Support Instrument (ESI) to help companies mitigate the financial risk of doing clinical trials for possible vaccines while already starting production, which might have to be halted if the trials fail.

EU launches funding drive for Covid-19 vaccine

The European Commission launches on Monday an initiative to raise €7.5bn to speed up the development of vaccines, treatment and testing capacity, ensuring that is equally "available to everyone and at affordable prices" and avoiding nationalisms.

EU wants to pay in advance for promising vaccines

EU health ministers will discuss on Friday plans to have the Commission negotiate with pharmaceutical companies on behalf of EU countries, make advaced payments and secure enough vaccines for Europeans.

EU Commission ready to play bigger role in health sector

The public health crisis caused by the coronavirus in member states has pushed the European Commission to play a more active in the field of health, especially funding the development of an effective Covid-19 vaccine.

EU seeks new deal for '90% effective' Covid-19 vaccine

After an experimental Covid-19 vaccine developed by the American giant Pfizer and its German partner BioNTech was found to be more than 90 percent effective, the EU announced that it will sign a contract for up to 300 million doses.

News in Brief

  1. French ambassador to return to US after Macron-Biden call
  2. Borrell: EU needs armed force independent of US
  3. Polish region does U-turn on gay rights
  4. Johnson makes fun of French anger on submarine deal
  5. Ukraine vows 'tough response' after gun attack on top aide
  6. Poland again delays ruling on primacy of EU law
  7. EU to table emergency proposals on gas-price surge
  8. EU delays first set of anti-greenwashing rules

EU medicines agency: booster shots not urgent

The European Medicines Agency said that there is no urgent need to administer booster shots to the general population, pointing out that the priority now should be to vaccinate the one-third of Europeans who are not fully vaccinated.

Stakeholders' Highlights

  1. Nordic Council of MinistersNATO Secretary General guest at the Session of the Nordic Council
  2. Nordic Council of MinistersCan you love whoever you want in care homes?
  3. Nordic Council of MinistersNineteen demands by Nordic young people to save biodiversity
  4. Nordic Council of MinistersSustainable public procurement is an effective way to achieve global goals
  5. Nordic Council of MinistersNordic Council enters into formal relations with European Parliament
  6. Nordic Council of MinistersWomen more active in violent extremist circles than first assumed

Latest News

  1. More French names linked to Russia election-monitoring
  2. Negotiations set for new, tougher, EU ethics body
  3. Lead energy MEP silent on gas meetings before vote
  4. WHO makes major cut in 'safe' air-pollution levels
  5. EU negotiators defend high Covid vaccines prices paid to pharma
  6. The EU's 'backyard' is not in the Indo-Pacific
  7. French MEPs lead bogus EU monitoring of Russia vote
  8. Europeans think new 'Cold War' is here - but not for them

Join EUobserver

Support quality EU news

Join us